Holding(s) in Company (1822379)
25 January 2024 - 4:30AM
UK Regulatory
Arix Bioscience PLC (ARIX)
Holding(s) in Company
24-Jan-2024 / 17:30 GMT/BST
=----------------------------------------------------------------------------------------------------------------------
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)
i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting Arix Bioscience Plc
rights are attached ii:
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii:
3. Details of person subject to the notification obligation iv
Name RTW Investments, LP
City and country of registered office (if applicable) New York, USA
4. Full name of shareholder(s) (if different from 3.) v
Name RTW Biotech Opportunities
Operating Ltd
City and country of registered office (if applicable) St Peter Port, Guernsey
5. Date on which the threshold was crossed or reached vi: 17/01/2024
6. Date on which issuer notified (DD/MM/YYYY): 22/01/2024
7. Total positions of person(s) subject to the notification obligation
% of voting rights Total
through financial of Total number of
% of voting rights attached instruments both voting rights held
to shares (total of 8. A) (total of 8.B 1 + 8.B in % in issuer (8.A +
2) (8.A + 8.B) vii
8.B)
Resulting situation on the date on 25.52 0.00% 25.52% 33,023,210
which threshold was crossed or reached
Position of previous notification (if
n/a n/a n/a
applicable)
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii
A: Voting rights attached to shares
Class/type of Number of voting rights ix % of voting rights
shares
Direct Indirect Direct Indirect
ISIN code (if possible)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
GB00BD045071 0 33,023,210 0.00% 25.52%
SUBTOTAL 8. A 33,023,210 25.52%
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Exercise/ Number of voting rights that may be acquired if
Type of financial Expiration Conversion Period the instrument is % of voting
instrument date x xi rights
exercised/converted.
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Physical or
Type of financial Expiration Exercise/ cash % of voting
instrument date x Conversion Number of voting rights rights
Period xi Settlement
xii
SUBTOTAL
8.B.2
9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and
does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying)
issuer xiii
Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal
entity (please add additional rows as necessary) xiv
% of voting rights if it % of voting rights through financial Total of both if it equals or
Name xv equals or is higher than the instruments if it equals or is higher than is higher than the notifiable
notifiable threshold the notifiable threshold threshold
Roderick Wong
RTW Investments
GP LLC
RTW Investments,
LP
RTW Biotech
Opportunities
Ltd
RTW Biotech
Opportunities 25.52% 0.00% 25.52%
Operating Ltd
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be
held
11. Additional information xvi
Place of completion London, UK
Date of completion 19/01/2024
-----------------------------------------------------------------------------------------------------------------------
Dissemination of a Regulatory Announcement, transmitted by EQS
Group. The issuer is solely responsible for the content of this
announcement.
-----------------------------------------------------------------------------------------------------------------------
ISIN: GB00BD045071
Category Code: HOL
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 2.3. Major shareholding notifications
Sequence No.: 299502
EQS News ID: 1822379
End of Announcement EQS News Service
=------------------------------------------------------------------------------------
Image link:
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1822379&application_name=news
(END) Dow Jones Newswires
January 24, 2024 12:30 ET (17:30 GMT)
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Apr 2023 to Apr 2024
